http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101484977-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4192 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-04 |
| filingDate | 2012-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101484977-B1 |
| titleOfInvention | Triazole Derivatives, Process for Preparing the Same and Pharmaceutical Composition Comprising the Same |
| abstract | TECHNICAL FIELD The present invention relates to triazole derivatives having excellent inhibitory activity on microsomal prostaglandin E 2 synthetase-1 (mPGES-1), a process for producing the same, and a pharmaceutical composition containing the same as an active ingredient. The triazole derivatives of the present invention can be effectively used for the treatment or prevention of inflammation, arthritis, hyperthermia, pain, cancer, stroke or bone diseases. |
| priorityDate | 2012-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.